Zim Laboratories Ltd.

View in App
122.40 -2.00 ▼-1.6%

26 April 2024, 04:02:41 PM
Volume: 430,733

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.zimlab.in
Market Cap 595.87 Cr.
Enterprise Value(EV) 638.80 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 3.37 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 36.34 Trailing Twelve Months Ending 2023-12
Industry PE 41.99 Trailing Twelve Months Ending 2023-12
Book Value / Share 47.36 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.58 Calculated using Price: 122.29
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 4.87 Cr. 48,725,814 Shares
FaceValue 10
About Zim Laboratories Ltd.
The company is engaged in the manufacturing of formulation on drugs and pre formulation on ingredients in India and marketing and selling these within and outside India.

Zim Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Zim Laboratories Ltd. Performance

View details >>
1 Day
-1.61%
1 Week
+28.17%
1 Month
+22.83%
3 Month
+12.29%
6 Month
+7.70%
1 Year
+57.53%
2 Year
5 Year
10 Year

Zim Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -22.94 5.29 17.21 15.07 10.73 2.17 4.66 8.65 13
Return on Capital Employed (%) -8.7 9.95 14.2 16.46 14.64 5.39 8.7 12.52 16.82
Return on Assets (%) -8.12 1.95 7.33 7.02 4.93 1.02 2.28 4.37 7.07

Zim Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 94 99 118 137 151 154 161 176 200 226
Non Curr. Liab. 38 35 18 17 20 23 19 20 37 44
Curr. Liab. 134 124 113 141 156 143 142 147 111 96
Minority Int.
Equity & Liab. 266 257 250 295 328 320 322 343 348 366
Non Curr. Assets 97 102 96 122 132 138 130 129 157 176
Curr. Assets 169 155 154 173 195 182 192 214 191 190
Misc. Exp. not W/O
Total Assets 266 257 250 295 328 320 322 343 348 366

Zim Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 266 269 235 273 335 278 307 333 399 355
Other Income 2 4 6 3 2 5 2 4 6 4
Total Income 269 272 241 276 337 282 310 338 405 359
Total Expenditure -245 -239 -204 -238 -293 -255 -268 -292 -347 -314
PBIDT 24 33 37 38 44 27 42 45 58 45
Interest -10 -14 -10 -9 -11 -13 -11 -8 -6 -6
Depreciation -7 -9 -9 -10 -11 -14 -16 -16 -17 -17
Taxation 5 0 1 -6 -7 3 -3 -6 -11 -6
Exceptional Items -33 -5 6 -5
PAT -22 5 19 19 15 3 7 15 24 16
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -22 5 19 19 15 3 7 15 24 16
Adjusted EPS -5 1 4 4 3 1 2 3 5 3

Zim Laboratories Ltd. Cash Flow

View details >>
Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 6 22 32 37 35 22 32 49 38
Cash Fr. Inv. -9 -12 -7 -26 -21 -19 -6 -15 -36
Cash Fr. Finan. -3 -10 -25 -10 -15 -2 -26 -33 1
Net Change -7 0 0 1 -1 0 2 2
Cash & Cash Eqvt 1 1 0 1 1 1 1 3 6

Zim Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 33.26 33.26 33.26 33.26 33.26 33.26 33.26 33.26 33.26
Public 66.74 66.74 66.74 66.74 66.74 66.74 66.74 66.74 66.74
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Zim Laboratories Ltd. Announcements

View details >>
Fri, 26 Apr 2024
Price movement
Significant movement in price has been observed in Zim Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Zim Laboratories Limited has submitted their response.
Thu, 25 Apr 2024
Price movement
Significant movement in price has been observed in Zim Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Thu, 25 Apr 2024
Loss/Duplicate-Share Certificate-XBRL
ZIM Laboratories Limited has informed the Exchange about Loss of share certificates

Zim Laboratories Ltd. Technical Scans

View details >>
Fri, 26 Apr 2024
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 1 Year High Increase in 1 Year
William %R Bearish William %R Bearish
CCI Overbought Zone CCI Overbought Zone

Zim Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,919.96 1,506.55 -0.9%
Cipla Ltd. 113,794.25 1,409.15 +0.2%
Divi's Laboratories Ltd. 106,860.39 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. 104,315.63 6,252.10 +0.5%
Zydus Lifesciences Ltd. 95,380.92 947.40 -0.4%
Mankind Pharma Ltd. 94,869.36 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. 91,057.05 2,691.00 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.52 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 30.69 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 77.27 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.95 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 54.93 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.95 2,691.00 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.78 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 4.39 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 8.20 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.88 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.06 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.73 2,691.00 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,691.00 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,691.00 -0.1%

Zim Laboratories Ltd. FAQ's

What is Zim Laboratories share price?
Can I buy Zim Laboratories shares now?
What is the Market Cap of Zim Laboratories?
What are the key metrics to analyse Zim Laboratories?
What is the 52 Week High and Low of Zim Laboratories?
What is the trend of Zim Laboratories share price?